Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gesine Bug

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
Bone Marrow Transplantation|April 14, 2025
Growing adoption of pharmacologic maintenance therapy after allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a survey on behalf of the EBMT acute leukemia working partyIman Abou Dalle, Myriam Labopin, Irma Khvedelidze, et al.
Journal of Medical Genetics|June 11, 2017
Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNAJohann-Christoph Jann, Daniel Nowak, Florian Nolte, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2014
Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study GroupThomas Schroeder, Elena Rachlis, Gesine Bug, et al.
Bone Marrow Transplantation|April 11, 2023
Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationIman Abou Dalle, Myriam Labopin, Nicolaus Kröger, et al.
Hemasphere|September 25, 2023
Thiotepa-busulfan-fludarabine Compared to Treosulfan-based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remission: A Study From the Acute Leukemia Working Party of the EBMTFrancesco Saraceni, Myriam Labopin, Anna M Raiola, et al.
Journal of Translational Medicine|June 13, 2024
Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host diseaseHalvard Bonig, Mareike Verbeek, Peter Herhaus, et al.
Transplantation and Cellular Therapy|August 28, 2022
Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic LeukemiaDietrich W Beelen, Renate Arnold, Matthias Stelljes, et al.
American Journal of Hematology|May 23, 2024
Peripheral blood stem cell versus bone marrow graft for patients ≥60 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationRaynier Devillier, Jacques-Emmanuel Galimard, Didier Blaise, et al.
Transplantation and Cellular Therapy|December 2, 2021
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor TransplantationArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
Blood Advances|October 5, 2024
Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in GermanyAysenur Arslan, Svenja Labuhn, Elisa Sala, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Bone Marrow Transplantation|April 14, 2025
Growing adoption of pharmacologic maintenance therapy after allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a survey on behalf of the EBMT acute leukemia working partyIman Abou Dalle, Myriam Labopin, Irma Khvedelidze, et al.
Journal of Medical Genetics|June 11, 2017
Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNAJohann-Christoph Jann, Daniel Nowak, Florian Nolte, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2014
Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study GroupThomas Schroeder, Elena Rachlis, Gesine Bug, et al.
Bone Marrow Transplantation|April 11, 2023
Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationIman Abou Dalle, Myriam Labopin, Nicolaus Kröger, et al.
Hemasphere|September 25, 2023
Thiotepa-busulfan-fludarabine Compared to Treosulfan-based Conditioning for Haploidentical Transplant With Posttransplant Cyclophosphamide in Patients With Acute Myeloid Leukemia in Remission: A Study From the Acute Leukemia Working Party of the EBMTFrancesco Saraceni, Myriam Labopin, Anna M Raiola, et al.
Journal of Translational Medicine|June 13, 2024
Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host diseaseHalvard Bonig, Mareike Verbeek, Peter Herhaus, et al.
Transplantation and Cellular Therapy|August 28, 2022
Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic LeukemiaDietrich W Beelen, Renate Arnold, Matthias Stelljes, et al.
American Journal of Hematology|May 23, 2024
Peripheral blood stem cell versus bone marrow graft for patients ≥60 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationRaynier Devillier, Jacques-Emmanuel Galimard, Didier Blaise, et al.
Transplantation and Cellular Therapy|December 2, 2021
Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor TransplantationArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
Blood Advances|October 5, 2024
Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in GermanyAysenur Arslan, Svenja Labuhn, Elisa Sala, et al.
Pageof 17